209 related articles for article (PubMed ID: 18815244)
1. IL-18 contributes to renal damage after ischemia-reperfusion.
Wu H; Craft ML; Wang P; Wyburn KR; Chen G; Ma J; Hambly B; Chadban SJ
J Am Soc Nephrol; 2008 Dec; 19(12):2331-41. PubMed ID: 18815244
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury.
Furuichi K; Wada T; Iwata Y; Kokubo S; Hara A; Yamahana J; Sugaya T; Iwakura Y; Matsushima K; Asano M; Yokoyama H; Kaneko S
Crit Care Med; 2006 Sep; 34(9):2447-55. PubMed ID: 16849996
[TBL] [Abstract][Full Text] [Related]
3. TLR4 activation mediates kidney ischemia/reperfusion injury.
Wu H; Chen G; Wyburn KR; Yin J; Bertolino P; Eris JM; Alexander SI; Sharland AF; Chadban SJ
J Clin Invest; 2007 Oct; 117(10):2847-59. PubMed ID: 17853945
[TBL] [Abstract][Full Text] [Related]
4. Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion.
Patel NS; Chatterjee PK; Di Paola R; Mazzon E; Britti D; De Sarro A; Cuzzocrea S; Thiemermann C
J Pharmacol Exp Ther; 2005 Mar; 312(3):1170-8. PubMed ID: 15572648
[TBL] [Abstract][Full Text] [Related]
5. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages.
Day YJ; Huang L; Ye H; Linden J; Okusa MD
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F722-31. PubMed ID: 15561971
[TBL] [Abstract][Full Text] [Related]
6. Effects of delayed rapamycin treatment on renal fibrosis and inflammation in experimental ischemia reperfusion injury.
Liu M; Agreda P; Crow M; Racusen L; Rabb H
Transplant Proc; 2009 Dec; 41(10):4065-71. PubMed ID: 20005342
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin expressed in tubular epithelial cells regulates NK cell-mediated kidney ischemia reperfusion injury.
Zhang ZX; Shek K; Wang S; Huang X; Lau A; Yin Z; Sun H; Liu W; Garcia B; Rittling S; Jevnikar AM
J Immunol; 2010 Jul; 185(2):967-73. PubMed ID: 20548025
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion.
Liang H; Xu F; Zhang T; Huang J; Guan Q; Wang H; Huang Q
Biomed Pharmacother; 2018 Oct; 106():879-889. PubMed ID: 30119258
[TBL] [Abstract][Full Text] [Related]
9. Maladaptive role of IL-6 in ischemic acute renal failure.
Kielar ML; John R; Bennett M; Richardson JA; Shelton JM; Chen L; Jeyarajah DR; Zhou XJ; Zhou H; Chiquett B; Nagami GT; Lu CY
J Am Soc Nephrol; 2005 Nov; 16(11):3315-25. PubMed ID: 16192425
[TBL] [Abstract][Full Text] [Related]
10. Endogenous IL-13 protects hepatocytes and vascular endothelial cells during ischemia/reperfusion injury.
Kato A; Okaya T; Lentsch AB
Hepatology; 2003 Feb; 37(2):304-12. PubMed ID: 12540780
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury.
Hui W; Jinxiang Z; Heshui W; Zhuoya L; Qichang Z
Biochem Biophys Res Commun; 2009 Nov; 389(2):328-32. PubMed ID: 19723506
[TBL] [Abstract][Full Text] [Related]
12. The effect of murine anti-thymocyte globulin on experimental kidney warm ischemia-reperfusion injury in mice.
Jang HR; Gandolfo MT; Ko GJ; Racusen L; Rabb H
Transpl Immunol; 2009 Dec; 22(1-2):44-54. PubMed ID: 19682579
[TBL] [Abstract][Full Text] [Related]
13. Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion.
Zhai Y; Qiao B; Gao F; Shen X; Vardanian A; Busuttil RW; Kupiec-Weglinski JW
Hepatology; 2008 Jan; 47(1):199-206. PubMed ID: 17935177
[TBL] [Abstract][Full Text] [Related]
14. Comparison of renal dysfunction in wild-type, IL-6 KO and iNOS KO mice hind limb tourniquet-reperfusion model.
Kato N; Abe S; Suto M; Hiraiwa K
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S248-51. PubMed ID: 19364673
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-33 signaling contributes to renal fibrosis following ischemia reperfusion.
Liang H; Xu F; Wen XJ; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
Eur J Pharmacol; 2017 Oct; 812():18-27. PubMed ID: 28668506
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with paricalcitol attenuates inflammation in ischemia-reperfusion injury via the up-regulation of cyclooxygenase-2 and prostaglandin E2.
Hwang HS; Yang KJ; Park KC; Choi HS; Kim SH; Hong SY; Jeon BH; Chang YK; Park CW; Kim SY; Lee SJ; Yang CW
Nephrol Dial Transplant; 2013 May; 28(5):1156-66. PubMed ID: 23229926
[TBL] [Abstract][Full Text] [Related]
17. Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury.
Burne-Taney MJ; Kofler J; Yokota N; Weisfeldt M; Traystman RJ; Rabb H
Am J Physiol Renal Physiol; 2003 Jul; 285(1):F87-94. PubMed ID: 12657560
[TBL] [Abstract][Full Text] [Related]
18. Expression of transforming growth factor-beta1 limits renal ischemia-reperfusion injury.
Guan Q; Nguan CY; Du C
Transplantation; 2010 Jun; 89(11):1320-7. PubMed ID: 20458271
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice.
Takeuchi D; Yoshidome H; Kato A; Ito H; Kimura F; Shimizu H; Ohtsuka M; Morita Y; Miyazaki M
Hepatology; 2004 Mar; 39(3):699-710. PubMed ID: 14999688
[TBL] [Abstract][Full Text] [Related]
20. Heparin binding epidermal growth factor in renal ischaemia/reperfusion injury.
Mulder GM; Nijboer WN; Seelen MA; Sandovici M; Bos EM; Melenhorst WB; Trzpis M; Kloosterhuis NJ; Visser L; Henning RH; Leuvenink HG; Ploeg RJ; Sunnarborg SW; van Goor H
J Pathol; 2010 Jun; 221(2):183-92. PubMed ID: 20225242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
